ChoA Pharmaceutical
Daily close in US$ at the latest USD/KRW close. Source: KRX via FinanceDataReader.
ChoA Pharmaceutical makes medicines and health-care products supplied to patients and health-care providers in South Korea.
The company is listed on KOSDAQ, South Korea's technology and small-cap stock exchange. The filing's table of contents covers a broad range of pharmaceutical products and services, along with active research and development activity, suggesting the business spans both established drug lines and pipeline work.
Summary is AI-generated and may contain errors · figures from DART filings
ChoA Pharmaceutical in five facts
What does ChoA Pharmaceutical do?
ChoA Pharmaceutical makes medicines and health-care products supplied to patients and health-care providers in South Korea.
Where is ChoA Pharmaceutical listed and in which sector?
ChoA Pharmaceutical (Korean name: 조아제약) trades under KRX code 034940 on KOSDAQ, the Korea Exchange's board for smaller and growth companies. It is classified in the Health Care sector, Pharmaceuticals.
How large is ChoA Pharmaceutical?
Its market capitalisation was US$9.3M on 2026-10-21, which puts it in this site's small-cap group. US$ amounts are converted from won at 1 USD ≈ ₩1,325 (2026-10-21).
What were ChoA Pharmaceutical's latest annual revenue and operating profit?
For fiscal year 2025, ChoA Pharmaceutical reported revenue of US$44.8M, an operating loss of US$5M and a net loss of US$5.6M, per its annual report on DART (data retrieved from DART on 2026-09-08). Revenue was down 5.4% on the previous year.
Where does this data come from?
Financial statements and filings come from DART, Korea's official corporate-filing system. Share prices, market capitalisation and trading status come from KRX. Company summaries are AI-generated from the filings and may contain errors; financial figures are mapped directly from DART.
Data sources and last updated
- Filings and financial statements
- DART (dart.fss.or.kr), Korea's official corporate-filing system
- Prices, market cap, trading status
- KRX (Korea Exchange), via FinanceDataReader
- Latest annual financials
- Fiscal year 2025, data retrieved from DART on 2026-09-08
- Share price and market cap
- Close of 2026-10-21
- Currency
- US$, converted from won at 1 USD ≈ ₩1,325 (2026-10-21 close)
- Company data updated
- 2026-10-21
- Company summary
- AI-generated from filings; may contain errors. Information only, not investment advice.
- Other market noticeOct 7
- Trading suspension (share consolidation/split registration)
The exchange suspended trading in ChoA Pharmaceutical's common shares starting 2026-08-05 until the day before the listing date of the changed new shares, due to an electronic-registration change/cancellation from a share consolidation.
M&A · Jul 31 - Change of 30% or more in revenue or profit/loss structure (15% for large companies)
ChoA Pharmaceutical reported consolidated results for FY2025: revenue of US$41.2M (−5.4% year on year), an operating loss of US$4.58M and a net loss of US$4.51M.
Earnings · Feb 19